United Kingdom
News & Events
Upcoming Events
EMMAC Life Sciences Group to Present at The Canaccord Genuity 4th Annual Cannabis Conference
Tuesday 12th May 2020 – Antonio Costanzo, Chief Executive Officer and Thomas Ellen, Chief Financial Officer, EMMAC Life Sciences Group to present at The Canaccord
Press Releases
EMMAC Life Sciences Group and Boiron selected for French Medical Cannabis trial
26 January 2021, London. EMMAC Life Sciences Group (“EMMAC” or the “Group” or the “Company”), Europe’s largest independent cannabis company, is pleased to announce
EMMAC Life Sciences Group and Yooma Corp. Enter into Licensing Agreement for EMMAC Wellness Brands
Partnership to accelerate growth and drive new market entry, with a focus on Asia London (UK), and Toronto (Canada), January 20, 2021 – EMMAC
EMMAC Life Sciences Group raises £15 million via successful issue of convertible notes
16 December 2020, London. EMMAC Life Sciences Group (“EMMAC” or the “Group” or the “Company”), Europe’s largest independent cannabis company, is pleased to announce
EMMAC Life Sciences Group provides Corporate Update
04 November 2020, London. EMMAC Life Sciences Group (“EMMAC” or the “Group” or the “Company”), Europe’s largest independent cannabis company, provides the following corporate
EMMAC Life Sciences Group announces UK manufacture of medical cannabis
16 October 2020, London. EMMAC Life Sciences Group (“EMMAC” or the “Group” or the “Company”), Europe’s largest independent cannabis company, is pleased to announce
EMMAC secures GDP licence for Swiss pharmaceutical entity, EMMAC SAGL
18 August 2020, London. EMMAC Life Sciences Group, Europe’s largest independent cannabis company, is pleased to announce that EMMAC SAGL, the Group’s pharmaceutical entity
